Simplexa® Flu A/B & RSV Kit
Reliable detection and differentiation of influenza A virus, influenza B virus and RSV
KIT for Infectious Diseases Overview
Background
The CDC estimates that influenza has resulted in up to 35.6 million illnesses, 710,000 hospitalizations, and as many as 56,000 deaths annually since 2010.1
Respiratory syncytial virus (RSV) infection is more prevalent in infants and toddlers and is a leading cause of hospitalization in this age group, but RSV also causes disease in adults that can be severe in certain populations.2
1. https://www.cdc.gov/flu/about/disease/burden.htm
2. MOL2650, Simplexa® Flu A/B & RSV Direct Kit Product Insert, Rev. F.
Why to choose it
Capable of running 94 patient samples at the same time.
For use on
Benefits
Reliable performance that you can count on
Simplexa® Flu A/B & RSV assay has 100% sensitivity and greater than 98% specificity.
Simplexa® Flu A/B and Culture/DFA Clinical Agreement
Influenza A
| Clinical Agreement | Prospective Samples |
Retrospective Samples |
|---|---|---|
| Clinical Agreement Sensitivity | Prospective Samples 100% |
Retrospective Samples 100% |
| Clinical Agreement Specificity | Prospective Samples 99.3% |
Retrospective Samples 100% |
Influenza B
| Clinical Agreement | Prospective Samples |
Retrospective Samples |
|---|---|---|
| Clinical Agreement Sensitivity | Prospective Samples 100% |
Retrospective Samples 100% |
| Clinical Agreement Specificity | Prospective Samples 99.8% |
Retrospective Samples 100% |
RSV
| Clinical Agreement | Prospective Samples |
Retrospective Samples |
|---|---|---|
| Clinical Agreement Sensitivity | Prospective Samples 98.0% |
Retrospective Samples 100% |
| Clinical Agreement Specificity | Prospective Samples 96.9% |
Retrospective Samples 96.0% |
Ordering info
| Product | Code | Reactions |
|---|---|---|
| Product Simplexa® Flu A/B & RSV Kit |
Code MOL2600 | Reactions 100 |
Our repository
All the answers you need.
Access our database to find:
instructions for use, safety data sheets,
assay protocols and more.